Versant Capital Management, Inc - ASSERTIO THERAPEUTICS INC ownership

ASSERTIO THERAPEUTICS INC's ticker is ASRT and the CUSIP is 04545L107. A total of 155 filers reported holding ASSERTIO THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.37 and the average weighting 0.0%.

Quarter-by-quarter ownership
Versant Capital Management, Inc ownership history of ASSERTIO THERAPEUTICS INC
ValueSharesWeighting
Q3 2019$0
-100.0%
59
-94.5%
0.00%
-100.0%
Q2 2019$3,000
-86.4%
1,070
-51.8%
0.00%
-80.0%
Q1 2019$22,000
+340.0%
2,221
+47.6%
0.01%
+150.0%
Q4 2018$5,000
-28.6%
1,505
+22.9%
0.00%
-33.3%
Q3 2018$7,0001,2250.00%
Other shareholders
ASSERTIO THERAPEUTICS INC shareholders Q3 2018
NameSharesValueWeighting ↓
TSP Capital Management Group, LLC 127,850$164,0000.08%
PERKINS CAPITAL MANAGEMENT INC 69,600$89,0000.08%
GLOBEFLEX CAPITAL L P 213,991$274,0000.06%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 1,500,000$1,920,000,0000.05%
DELTEC ASSET MANAGEMENT LLC 162,700$208,0000.05%
Spark Investment Management LLC 285,588$365,0000.05%
Factorial Partners, LLC 37,000$47,360,0000.04%
HighVista Strategies LLC 43,400$56,0000.04%
OAKTREE CAPITAL MANAGEMENT LP 1,492,455$1,910,0000.04%
OXFORD ASSET MANAGEMENT LLP 1,036,375$1,327,0000.03%
View complete list of ASSERTIO THERAPEUTICS INC shareholders